β 2-adrenergic receptor haplotype linked to intubation and mechanical ventilation in children with asthma

Journal of Asthma

Volumn 49, Issue 6, 2012, Pages 563-568

  Carroll, Christopher L ^a   Sala, Kathleen A ^a   Zucker, Aaron R ^a   Schramm, Craig M ^a  

^a Division of Pediatric Infectious Diseases   (United States)

Author keywords

Asthma; Genetics; Pediatrics

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; GLUTAMIC ACID; GLUTAMINE; GLYCINE;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; CHILD; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; ETHNICITY; FEMALE; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; SCHOOL CHILD;

ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HAPLOTYPES; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; MALE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY;

EID: 84863908895     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2012.701362     Document Type: Article

References (24)

1. National Heart, Lung and Blood Institute. Guidelines for the Diagnosis and Management of Asthma, Expert Panel Report 3. Publication no. 07-4051. Bethesda, MD: National Institutes of Health, 2007
2. Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, Scalia MR, Akinbami LJ. National surveillance for asthma-United States, 1980-2004. MMWR 2007; 56:18-54.
3. Pendergraft TB, Stanford RH, Beasley R, Stempel DA, Roberts C, McLaughlin T. Rates and characteristics of intensive care unit admissions and intubations among asthma-Related hospitalizations. Ann Allergy Asthma Immunol 2004; 93:1-2.
4. Brenner B, Corbridge T, Kazzi A. Intubation and mechanical ventilation of the asthmatic patient in respiratory failure. Proc Am Thorac Soc 2009; 6:371-379.
5. Carroll CL, Smith SR, CollinsM, Bhandari A, Schramm CM, Zucker AR. Endotracheal intubation and pediatric status asthmaticus: Site of original care affects treatment. Pediatr Crit Care Med 2007; 8:91-95.
6. Kardon EM. Acute asthma. Emerg Med Clin North Am 1996; 14:93-114.
7. LeSon S, Gershwin ME. Risk factors for asthmatic patients requiring intubation. I. Observations in children. J Asthma 1995; 32:285-294.
8. LeSon S, Gershwin ME. Risk factors for asthmatic patients requiring intubation. II. Observations in teenagers. J Asthma 1995; 32:379-389.
9. Mitchell I, Tough S, Semple LK, Green FH, Hessel PA. Near-Fatal asthma: A population-Based study of risk factors. Chest 2002; 121: 1407-1413.
10. Turner MO, Noertjojo K, Vedal S, Bai T, Crump S. Risk factors for nearfatal asthma. Am J Respir Crit Care Med 1998; 157:1804-1809.
11. Alvarez GG, Schulzer M, Jung D, FitzGerald JM. A systematic review of risk factors associated with near-Fatal and fatal asthma. Can Respir J. 2005; 12:265-270.
12. Carroll CL, Schramm CM, Zucker AR. Severe exacerbations in children with mild asthma. J Asthma 2008; 45(6):513-517.
13. Carroll CL, Stoltz P, Schramm CM, Zucker AR. ß2-Adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations. Chest 2009; 135:1186-1192.
14. Carroll CL, Sala K, Zucker AR, Schramm CM. Beta-Adrenergic receptor polymorphisms and response to therapy in pediatric status asthmaticus: A prospective cohort study. Pediatr Pulmonol 2012; 47:233-239.
15. Elbahlawan L, Binaei S, Christensen ML, Zhang Q, Quasney MW, Dahmer MK. Beta2-Adrenergic receptor polymorphisms in African American children with status asthmaticus. Pediatr Crit Care Med 2006; 7:87-89.
16. Turner SW, Khoo SK, Laing IA, Palmer LJ, Gibson NA, Rye PR, Landau LI, Goldblatt J, Le Souef PN. Beta2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children. Clin Exp Allergy 2004; 34:1043-1048.
17. Kotani Y, Nishimura Y, Maeda H, Yokoyama M. Beta2-Adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics. J Asthma 1999; 36:583-590.
18. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF Jr, Liggett SB, Martin RJ, Mitra N, Peters SP, Silverman E, Sorkness CA, Szefler SJ, Wechsler ME, Weiss ST, Drazen JM, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Use of regularly scheduled albuterol treatment in asthma: genotype-Stratified, randomised, placebo-Controlled cross-over trial. Lancet 2004; 4:1505-1512.
19. Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, Fahy JV, Jarjour N, Kazani S, Kim S, Kraft M, Lazarus SC, Lemanske RF Jr, Markezich A, Martin RJ, Permaul P, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Walter MJ, Wasserman SI, Israel E, National Heart, Lung and Blood Institute's Asthma Clinical Research Network. Effect of beta2-Adrengergic receptor polymorphism on response to long-Acting beta2 agonist in asthma (LARGE trial): A genotype-Stratified, randomised, placebo-Controlled, crossover trial. Lancet 2009; 374:1754-1764.
20. Finkelstein Y, Bournissen FG, Hutson JR, Shannon M. Polymorphismof the ADRB2 gene and response to inhaled beta-Agonists in children with asthma: A meta-Analysis. J Asthma 2009; 46:900-905.
21. Carroll CL, Schramm CM. Protocol-based titration of intravenous terbutaline decreases length of stay in pediatric status asthmaticus. Pediatr Pulmonol 2006; 41:350-356.
22. Carroll CL, Sekaran AK, Lerer TJ, Schramm CM. A modified pulmonary index score with predictive value for pediatric asthma exacerbations. Ann Allergy Asthma Immunol 2005; 94:355-359.
23. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL. CDC growth charts: United States advance data from vital and health statistics, no. 314.Hyattsville, MD: National Center for Health Statistics, 2000.
24. Green SA, Turki J, Innis M, Liggett SB. Amino-Terminal polymorphisms of the human beta 2-Adrenergic receptor impart distinct agonistpromoted regulatory properties. Biochemistry 1994; 33:9414-9419.